Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 929.00
+10.00 (1.09%)
Sep 12, 2025, 3:30 PM JST
Takara Bio Market Cap
Takara Bio has a market cap or net worth of 111.87 billion as of September 12, 2025. Its market cap has decreased by -12.44% in one year.
Market Cap
111.87B
Enterprise Value
90.21B
Revenue
45.81B
Ranking
n/a
PE Ratio
193.87
Stock Price
929.00
Market Cap Chart
Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 111.87B, an increase of 105.27%. That is a compound annual growth rate of 3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 111.75B | -11.62% |
| Dec 30, 2024 | 126.44B | -16.13% |
| Dec 29, 2023 | 150.76B | -27.34% |
| Dec 30, 2022 | 207.48B | -34.83% |
| Dec 30, 2021 | 318.38B | -4.48% |
| Dec 30, 2020 | 333.31B | 34.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 10.96T |
| Takeda Pharmaceutical Company | 7,100.82B |
| HOYA Corporation | 7,092.53B |
| Daiichi Sankyo Company | 6,581.95B |
| Otsuka Holdings | 4,391.94B |
| Terumo | 3,820.39B |
| Astellas Pharma | 3,004.14B |
| Shionogi & | 2,261.92B |